COMMUNIQUÉS West-GlobeNewswire

La collaboration entre Crown Bioscience et The Jackson Laboratory permet un accès mondial au modèle murin FATZO

07/03/2019 - 01:19

La collaboration continue facilite la distribution mondiale de l’obésité, des maladies métaboliques et du modèle NASH ainsi que l’approvisionnement prioritaire à la plateforme mondiale de maladies cardiovasculaires, de [...]

Zafgen to Host Conference Call to Discuss Fourth Quarter and Full Year 2018 Financial Results

07/03/2019 - 00:00

BOSTON, March 06, 2019 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients [...]

MRI Interventions, Inc. to Announce Fourth Quarter and Full Year 2018 Results on March 11

06/03/2019 - 23:29

IRVINE, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a platform neurosurgery company with products designed to deliver navigation, ablation, deep brain stimulation, biopsy and gene [...]

Innovative Cellular Therapeutics Announces Opening of U.S. Office and Appointment of New Members to Executive Leadership Team

06/03/2019 - 23:00

Accomplished Industry Leaders Join ICT to Spearhead U.S. Clinical Development Efforts ROCKVILLE, Md., March 06, 2019 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics (ICT), a biotechnology company developing [...]

Aptevo Announces Proposed Public Offering of Common Stock and Warrants

06/03/2019 - 22:37

SEATTLE, March 06, 2019 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq: APVO), a biotechnology company focused on developing novel oncology, autoimmune and hematology therapeutics, today announced that it intends [...]

Rockwell Medical, Inc. to Discuss Fourth Quarter and Full Year 2018 Financial Results on March 14, 2019

06/03/2019 - 22:30

WIXOM, Mich., March 06, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. ("Rockwell Medical" or the “Company”) (Nasdaq: RMTI) today announced that the Company will release its 2018 fourth quarter and full year financial [...]

Idera Pharmaceuticals Reports Fourth Quarter and Year End 2018 Financial Results and Provides Corporate Update

06/03/2019 - 22:30

– ILLUMINATE-301 Enrollment on Track for Completion Q4 2019 – – ILLUMINATE-204 Enrollment Complete; Data Anticipated Q4 2019 – – ILLUMINATE-206 Trial Expected to Initiate Q2 2019 – – Chief Medical Officer Dr. Joanna [...]

INSYS Therapeutics to Report Fourth Quarter and Full Year 2018 Results on March 7

06/03/2019 - 22:15

PHOENIX, March 06, 2019 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced [...]

Nephros to Report Fourth Quarter and Year End 2018 Financial Results on March 12th, 2019

06/03/2019 - 22:15

SOUTH ORANGE, NJ, March 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, [...]

Xeris Pharmaceuticals Announces Fourth Quarter and Full Year 2018 Financial Results and Highlights Pipeline Progress

06/03/2019 - 22:10

Continuing to execute commercial build and launch readiness for Gvoke HypoPen™ Advancing pipeline of preclinical and clinical development-stage products Cash position of $112.6 million at year-end 2018; February 2019 [...]

Supernus to Present at the 2019 Cowen Health Care Conference

06/03/2019 - 22:10

ROCKVILLE, Md., March 06, 2019 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASADQ: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]

Adverum Biotechnologies Reports Fourth Quarter 2018 Financial Results and Provides Corporate Update

06/03/2019 - 22:10

Advancing Novel Gene Therapy ADVM-022 for Wet AMD in OPTIC Phase 1 Clinical Trial MENLO PARK, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy [...]

Portola Pharmaceuticals to Webcast Presentation at Cowen and Company’s 39th Annual Health Care Conference

06/03/2019 - 22:10

SOUTH SAN FRANCISCO, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA) today announced that Scott Garland, Portola’s president and chief executive officer, will present a [...]

Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock

06/03/2019 - 22:05

TUSTIN, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by [...]

Avinger Provides Fourth Quarter and Full Year 2018 Shareholder Update

06/03/2019 - 22:05

Pantheris Fourth Quarter Revenue Increases 18% Over Prior Quarter REDWOOD CITY, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device company marketing the first and [...]

Teladoc Health to Participate in Upcoming Investor Conference

06/03/2019 - 22:05

PURCHASE, N.Y., March 06, 2019 (GLOBE NEWSWIRE) -- Teladoc Health , Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Jason Gorevic, chief executive officer, will participate in the following [...]

The Ensign Group Acquires Home Health and Hospice Operations in San Antonio, Texas

06/03/2019 - 22:05

MISSION VIEJO, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice care, [...]

Dynavax to Present at 39th Annual Cowen Healthcare Conference

06/03/2019 - 22:05

BERKELEY, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), a fully-integrated biopharmaceutical company focused on discovering and developing novel vaccines and immuno-oncology [...]

SI-BONE, Inc. Announces Journal of Bone and Joint Surgery (JBJS) Publishes 2-Year Results from iMIA, a European Multicenter Randomized Controlled Trial (RCT) of SI Joint Fusion with iFuse Implant System® vs Conservative Care

06/03/2019 - 22:05

This is the 67th peer-reviewed iFuse publication and shows rapid and sustained improvements in pain, patient function and quality of life, consistent with INSITE, a U.S. RCT published in August, 2016 SANTA CLARA, Calif [...]